Protalix BioTherapeutics Inc.

ASE:PLX   4:00:00 PM EDT
1.48
-0.06 (-3.90%)
: $1.47 -0.01 (-0.68%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)113.22M
Current PE28.97
Forward PE 10.57
2yr Forward PE 3.29
See more stats
Estimates Current Quarter
Revenue$15.53 Million
Adjusted EPS$0.04
See more estimates
10-Day MA$1.47
50-Day MA$1.92
200-Day MA$1.87
See more pivots

Protalix BioTherapeutics Inc. Stock, ASE:PLX

2 University Plaza, Suite 100, Hackensack, New Jersey 07601
United States of America
Phone: +1.201.696.9345
Number of Employees: 213

Description

Protalix Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development, production, and commercialization of recombinant therapeutic proteins based on plant cell based expression system. Its products include Alidornase alfa, PRX-115 and PRX-11. The company was by Yoseph Shaaltiel in 1993 and is headquartered in Hackensack, NJ.